NCT06758908

Brief Summary

prevelance, predictors and outcome of sepsis associated liver injury (SALI)

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
5mo left

Started Apr 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Apr 2025Oct 2026

First Submitted

Initial submission to the registry

December 14, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

January 6, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

April 1, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

January 6, 2025

Status Verified

December 1, 2024

Enrollment Period

1.4 years

First QC Date

December 14, 2024

Last Update Submit

December 28, 2024

Conditions

Liver Injuries

Outcome Measures

Primary Outcomes (3)

  • prevelance, predictors and outcome of sepsis associated liver injury (SALI)

    analysis outcome of sepsis associated liver injury (SALI)

    baseline

  • 28 days mortality

    patient with liver dieases and sepsis

    baseline

  • patient shouldn't be in pain

    patient in study not in pain

    baseline

Secondary Outcomes (1)

  • patient stay in hospital 2weeks

    baseline

Study Arms (1)

SALI

Device: Antibiotic

Interventions

AntibioticDEVICE

SALI

SALI

Eligibility Criteria

Age15 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

all people between 15 to 75 years

You may qualify if:

  • clinical diagnosis of SALI
  • must take liver support

You may not qualify if:

  • SALI
  • Thyroid disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Antibiotic Prophylaxis

Intervention Hierarchy (Ancestors)

ChemopreventionDrug TherapyTherapeuticsPremedication

Central Study Contacts

Mahmoud sayed zohry, first mastar

CONTACT

01225463889mzohry789@yahoo.com

Dinal ali hamad dina hamad, specialist

CONTACT

01063040703dinaalihamad@aun.edu

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assiut university

Study Record Dates

First Submitted

December 14, 2024

First Posted

January 6, 2025

Study Start

April 1, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

January 6, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share